In this issue:
Bimekizumab for moderate-to-severe plaque psoriasis
Risk of psoriasis according to BMI
Skin advanced glycation end products for monitoring psoriasis
Eczematous drug eruption with anti-IL-17A
Prevalence and factors associated with sleep disturbance with psoriasis
Three titration methods for apremilast for chronic plaque psoriasis
Clinical severity scores correlate with QoL in children with psoriasis
Supplemental essential phospholipids for moderate psoriasis
MTHFR gene polymorphisms, PsA risk and methotrexate hepatotoxicity
SC vs oral methotrexate for psoriasis vulgaris
Please login below to download this issue (PDF)